Gene · 7225
Papers2,972
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,972
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia. | Sci Transl Med | 2024 | 38865484 | PubTator, text mining | PubMed |
| Interaction between TRP channels and anoctamins. | Cell Calcium | 2024 | 38823351 | PubTator, text mining | PubMed |
| TRPC6 Knockout Alleviates Renal Fibrosis through PI3K/AKT/GSK3B Pathway. | Curr Med Sci | 2024 | 38748370 | PubTator, text mining | PubMed |
| TRPC3 Is Downregulated in Primary Hyperparathyroidism. | Int J Mol Sci | 2024 | 38673977 | PubTator, text mining | PubMed |
| Novel targets and their functions in the prognosis of uterine corpus endometrial cancer patients. | J Appl Genet | 2024 | 38639843 | PubTator, text mining | PubMed |
| PCC0208057 as a small molecule inhibitor of TRPC6 in the treatment of prostate cancer. | Front Pharmacol | 2024 | 38567350 | PubTator, text mining | PubMed |
| [Expansion of the genotypic and phenotypic spectrum and treatment of four children with Steroid-resistant nephrotic syndrome due to variants of TRPC6 gene]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 38565515 | PubTator, text mining | PubMed |
Corrigendum to "Trpc6 knockout improves behavioral dysfunction and reduces Aβ production by inhibiting CN-NFAT1 signaling in T2DM mice" [Experimental Neurology 363 (2023) 114350/manuscript number: EXNR-22-846]. | Exp Neurol | 2024 | 38553399 | PubTator, text mining | PubMed |
| Pharmacological Activation of TRPC6 Channel Prevents Colitis Progression. | Int J Mol Sci | 2024 | 38397074 | PubTator, text mining | PubMed |
| Voltage tunes mGlu5 receptor function, impacting synaptic transmission. | Br J Pharmacol | 2024 | 38369690 | PubTator, text mining | PubMed |
| Exploring metformin monotherapy response in Type-2 diabetes: Computational insights through clinical, genomic, and proteomic markers using machine learning algorithms. | Comput Biol Med | 2024 | 38368755 | PubTator, text mining | PubMed |
| A Dual Role of Mesenchymal Stem Cell Derived Small Extracellular Vesicles on TRPC6 Protein and Mitochondria to Promote Diabetic Wound Healing. | ACS Nano | 2024 | 38290527 | PubTator, text mining | PubMed |
| The Healthy and Diseased Retina Seen through Neuron-Glia Interactions. | Int J Mol Sci | 2024 | 38256192 | PubTator, text mining | PubMed |
| Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy. | J Transl Med | 2024 | 38246995 | PubTator, text mining | PubMed |
| Cytoskeleton Rearrangement in Podocytopathies: An Update. | Int J Mol Sci | 2024 | 38203817 | PubTator, text mining | PubMed |
| Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells. | Cells | 2024 | 38201302 | PubTator, text mining | PubMed |
| Beyond the kidney biopsy: genomic approach to undetermined kidney diseases. | Clin Kidney J | 2024 | 38186885 | PubTator, text mining | PubMed |
| Discovery of N-alkyl-N-benzyl thiazoles as novel TRPC antagonists for the treatment of glioblastoma multiforme. | Eur J Med Chem | 2024 | 38185057 | PubTator, text mining | PubMed |
| Idiopathic collapsing glomerulopathy is associated with APOL1 high-risk genotypes or Mendelian variants in most affected individuals in a highly admixed population. | Kidney Int | 2024 | 38143038 | PubTator, text mining | PubMed |
| Trpc6 knockout protects against renal fibrosis by restraining the CN‑NFAT2 signaling pathway in T2DM mice. | Mol Med Rep | 2024 | 38038121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7225/papers?page=8